Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety

References

• Almeida OP, Lautenschlager N, Vasikaram S, Leedman P, Flicker L. 2005. Association between physiological serum concentration of estrogen and the mental health of community dwelling postmenopausal women age 70 years and over. Am J Ger Psychiatry 13:142–149.
   PubMedGoogle Scholar
• American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders. 4th Washington, DC: American Psychiatric Association.
   Google Scholar
• Beck AT, Epstein N, Brown G, Steer RA. 1988. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893–897.
   PubMed Web of Science ®Google Scholar
• Begliuomini S, Casarosa E, Pluchino N, Lenzi E, Centofanti M, Freschi L, . 2007. Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum Reprod 22:995–1002.
   PubMed Web of Science ®Google Scholar
• Bramham CR, Messaoudi E. 2005. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 76:99–125.
   PubMed Web of Science ®Google Scholar
• Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg JB, Pagano M, . 2005. Influence of psychiatric comorbidity on recovery and recurrence in generalizedanxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 162:1179–1187.
   PubMed Web of Science ®Google Scholar
• Bus BAA, Molendijk ML, Penninx BJWH, Buitelaar JK, Kenis G, Prickaerts J, . 2011. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology 36:228–239.
   PubMed Web of Science ®Google Scholar
• Cohen J. 1988. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates.
   Google Scholar
• Chen Z-Y, Jing D, Bath KG, Ieraci A, Khan T, Siao C-J, . 2006. Genetic variant BDNF (val66met) polymorphism alters anxiety-related behavior. Science 314:140–143.
   PubMed Web of Science ®Google Scholar
• Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, . 2003. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395.
   PubMed Web of Science ®Google Scholar
• David DJ, Samuels BA, Rainer Q, Wang J-W, Marsteller D, Mendez I, . 2009. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62:479–493.
   PubMed Web of Science ®Google Scholar
• Duman RS, Monteggia LM. 2006. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116–1127.
   PubMed Web of Science ®Google Scholar
• Duman RS, Heninger GR, Nestler EJ. 1997. A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597–606.
   PubMed Web of Science ®Google Scholar
• Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. 2003. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide victims. Arch Gen Psychiatry 60: 804–815.
   PubMed Web of Science ®Google Scholar
• Gass P, Hellweg R. 2010. Peripheral brain-derived neurotrophic factor (BDNF) levels as a biomarker for affective disorders. Int J Neuropsychopharmacol 13:1–4.
   PubMedGoogle Scholar
• Govindarajan A, Rao BSS, Nair D, Trinh M, Mawjee N, Tonegawa S, . 2006. Transgenic brain-derived neurotrophic expression causes both anxiogenic and antidepressant effects. Proc Natl Acad Sci USA 103:13208–13213.
   PubMed Web of Science ®Google Scholar
• Green MJ, Matheson SL, Sheperd A, Weickert CS, Carr VJ. 2010. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol Psychiatry (advance online publication, 24 2010; 10.1038/mp.2010.88).
   Google Scholar
• Groves JO. 2008. Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry 12:1079–1088.
   Google Scholar
• Huang TL, Lee CT, Liu YL. 2008. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants. J Psychiatr Res 42:521–525.
   PubMed Web of Science ®Google Scholar
• Kabacoff RI, Segal DL, Hersen M, van Hasselt VB. 1997. Psychometric properties and diagnostic utility of the Beck anxiety inventory and the state-trait anxiety inventory with older adult psychiatric outpatients. J Anxiety Disord 11:33–47.
   PubMed Web of Science ®Google Scholar
• Kapczinski F, Dal-Pizzol F, Teixera AL, Magalhaes PVS, Kauer-Sant'Anna M, Klamt F, . 2010. A systematic toxicity index developed to assess peripheral changes in mood episodes. Mol Psychiatry 15:784–786.
   PubMed Web of Science ®Google Scholar
• Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. 2002a. Decreased serum brain-derived neurotrophic factor in major depressed patients. Psychiatry Res 109:143–148.
   PubMed Web of Science ®Google Scholar
• Karege F, Schwald M, Cisse M. 2002b. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 328:261–264.
   PubMed Web of Science ®Google Scholar
• Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubrey J-M, Bertschy G. 2005. Low brain-derived neurotrophic factor (BDNF) levels in serum probably result from lowered platelet BDNF release unrelated to BDNF reactivity. Biol Psychiatry 57:1068–1072.
   PubMed Web of Science ®Google Scholar
• Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. 1992. Major depressive disorder and generalized anxiety disorder. Same genes, (partly) different environments? Arch Gen Psychiatry 49:716–722.
   PubMed Web of Science ®Google Scholar
• Kendler KS, Walters EE, Neale MC, Kessler RC, Heath AC, Eaves LJ. 1995. The structure of the genetic and environmental risk factors for six major psychiatric disorders in women: phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism. Arch Gen Psychiatry 52:374–383.
   PubMed Web of Science ®Google Scholar
• Klaassen T, Klumperbeek J, Deutz NE, van Praag HM, Griez E. 1998. Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge. Psychiatr Res 77:167–174.
   PubMed Web of Science ®Google Scholar
• Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M, . 2010. Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol 14:347–353.
   PubMedGoogle Scholar
• Kobayashi K, Shimuzu E, Hashimoto K, Mitsumori M, Koike K, Okamura N, . 2005. Serum Brain-Derived Neurotrophic Factor (BDNF) levels in patients with panic disorder: As a biological predictor of response to group cognitive behavioral therapy. Prog Neuro-Psychopharmacol Biol Psychiatry 29:658–663.
   PubMed Web of Science ®Google Scholar
• Krishnan V, Nestler EJ. 2010. Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry 167:1305–1320.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Lowe B. 2007. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Int Med 146:317–325.
   PubMed Web of Science ®Google Scholar
• Kulkarni J, de Castella A, Fitzgerald PB, Gurvich CT, Bailey M, Burger H. 2008. Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry 65:955–960.
   PubMed Web of Science ®Google Scholar
• Lyketos CG, Nestadt G, Cwi J, Heithoff K, Eaton WW. 1994. The life chart interview: a standardized method to describe the course of psychopathology. Int J Methods Psychiatr Res 4:143–155.
   Google Scholar
• Maron E, Toru I, Vasar V, Shlik J. 2004. The effect of 5-hydroxy trypthophan on cholecystokinin-4-induced panic attacks in healthy volunteers. J Psychopharmacol 18:194–199.
   PubMedGoogle Scholar
• Martinowich K, Manji H, Lu B. 2007. New insights into BDNF function in depression and anxiety. Nat Neurosci 10:1089–1093.
   PubMed Web of Science ®Google Scholar
• Molendijk ML, Bus BAA, Spinhoven PH, Penninx, BJWH, Kenis G, Prickaerts, . 2010. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state and trait issues, clinical features, and pharmacological treatment. Mol Psychiatry (e-pub ahead of print 21 September 2010; doi: 10.1038/mp201098).
   Google Scholar
• Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S, . 2007. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry 61:187–197.
   PubMed Web of Science ®Google Scholar
• Nakazato M, Hashimoto K, Shimuzu E, Kumakiri C, Koizumi H, Okamura N, . 2003. Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders. Biol Psychiatry 54:485–490.
   PubMed Web of Science ®Google Scholar
• Penninx BJW, Beekman ATH, Smit JH, Zitman FG, Nolen WA, Spinhoven PH, . for the NESDA Research Consortium. 2008. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res 17:121–140.
   PubMed Web of Science ®Google Scholar
• Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. 1996. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 26:477–486.
   PubMed Web of Science ®Google Scholar
• Sartorius A, Hellweg R, Litzke J, Vogt M, Dormann C, Vollmayr B, . 2009. Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 42:270–276.
   PubMed Web of Science ®Google Scholar
• Scharfman HE, MacLusky NJ. 2004. Similarities between actions of estrogen and BDNF in the hippocampus: coincidence or clue? Trends Neursci 28:79–85.
   Google Scholar
• Seeman MV. 1997. Psychopathology in women and men: focus on female hormones. Am J Psychiatry 154:1641–1647.
   PubMed Web of Science ®Google Scholar
• Sen S, Duman R, Sanacora G 2008. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 64: 527–532.
   PubMed Web of Science ®Google Scholar
• Strohle A, Stoy M, Graetz B, Scheel M, Wittman A, Galinat J, . 2010. Acute exercise ameliorates reduced brain-derived neurotrophic factor in patients with panic disorder. PNEC 35:364–368.
   Google Scholar
• Wacker HR, Battegay R, Mullejans R, Schlosser C (2006). Using the CIDI-C in the general population. In: Stefanis CN, Rabavilas AD, Soldatos CR, Psychiatry: a world perspective. Amsterdam, The Netherlands: Elsevier Science Publishers.
   Google Scholar
• Walf AA, Frye CA. 2006. A review and update of mechanisms of estrogen in the hippocampus and amygdale for anxiety and depression behavior. Neuropsychopharmacology 31: 1097–1111.
   PubMed Web of Science ®Google Scholar
• Wittchen HU, Robins LN, Cottler LB, Sartorius N, Burke JD, Regier D. 1991. Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The multicentre WHO/ADAMHA field trials. Br J Psychiatry 159:645–653.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). 2010. Collaborating centre for drug statistics methodology. Anatomical Therapeutic Chemical (ATC) Classification (http://www.whocc.no/atcddd; accessed April 2010).
   Google Scholar
• Young E, Korszun A. 2010. Sex trauma, stress hormones and depression. MolPsychiatry 15:23–28.
   Google Scholar
• Ziegenhorn A, Schulte-Herbruggen O, Danker-Hopfe M, Malbranc H, Hartung D, Anders U, . 2007. Serum neurotrophins – a study on the time course and influencing dactors in a large old age sample. Neurobiol Aging 28:1436–1445.
   PubMed Web of Science ®Google Scholar